Oncolytic Virus Therapy Market to Grow Significantly at a CAGR of 24.9% by 2025 | Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma

The research report, titled "Global Oncolytic Virus Therapy Market" offers a clear understanding of the subject matter. The report has been hoarded using primary and secondary research methodologies. Both these methods are intended towards collaborating accurate and exact data relating the market dynamics, historical events, and the current market scenario. Moreover, Oncolytic Virus Therapy market also includes a SWOT analysis that determines the strengths, weaknesses, opportunities, and threats impacting the segments of the overall market.

In 2018, the global Oncolytic Virus Therapy market size was 2 million US$ and it is expected to reach 14 million US$ by the end of 2025, with a CAGR of 24.9% during 2019-2025.

Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn't until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

Inquire for Sample Copy of this Report:
https://www.marketinsightsreports.com/reports/04301206616/global-oncolytic-virus-therapy-market-size-status-and-forecast-2019-2025/inquiry?source=openpr&Mode=07

The report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market. Top Companies in the Global Oncolytic Virus Therapy Market: Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics, Cold Genesys and others.

Latest Industry News:

SAN DIEGO and CALGARY, Alberta, April 2, 2020 - Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced positive clinical data published in a peer-reviewed journal highlighting that the combination of FOLFIRI, bevacizumab and pelareorep was well tolerated, with promising efficacy signals in colorectal cancer patients with KRAS mutated tumors. The article, entitled "Elucidation of Pelareorep Pharmacodynamics in a Phase I Trial in Patients with KRAS Mutated Colorectal Cancer," authored by Dr. Sanjay Goel, Department of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, et al., was published on March 10, 2020, in Molecular Cancer Therapeutics.

February 20, 2020 - Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces that the first patient has successfully received TG6002, via an intrahepatic artery (IHA) infusion, as a locoregional treatment for unresectable liver metastases from colorectal cancer (CRLM). This procedure was performed at the NHS St James's University Hospital in Leeds (United Kingdom). Dr. Adel Samson, Academic Medical Oncologist at The Leeds Teaching Hospitals NHS Trust and The University of Leeds, is the Chief Investigator of this trial. TG6002 is a next-generation oncolytic virus which has multiple mechanisms of action, both directly in the tumor micro-environment and systemically.

Global Oncolytic Virus Therapy Market Split by Product Type and Applications:

This report segments the global Oncolytic Virus Therapy market on the basis of Types are:
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses

On the basis of Application, the Global Oncolytic Virus Therapy market is segmented into:
Melanoma
Prostate-Cancer
Breast-Cancer
Ovarian-Cancer
Others

Regional Analysis For Oncolytic Virus Therapy Market:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Browse the report description and TOC:
https://www.marketinsightsreports.com/reports/04301206616/global-oncolytic-virus-therapy-market-size-status-and-forecast-2019-2025?source=openpr&Mode=07

Influence of the Oncolytic Virus Therapy Market Report:

-Comprehensive assessment of all opportunities and risk in the Oncolytic Virus Therapy market.
-Detailed study of business strategies for growth of the Oncolytic Virus Therapy market-leading players.
-Conclusive study about the growth plot of Oncolytic Virus Therapy market for forthcoming years.
-In-depth understanding of Oncolytic Virus Therapy market-particular drivers, constraints and major micro markets.
-Favourable impression inside vital technological and market latest trends striking the Oncolytic Virus Therapy market.

What are the market factors that are explained in the report?

-Key Strategic Developments: The study also includes the key strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

-Key Market Features: The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

-Analytical Tools: The Global Oncolytic Virus Therapy Market report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porter's five forces analysis, SWOT analysis, feasibility study, and investment return analysis have been used to analyze the growth of the key players operating in the market.

Purchase Full Report:
https://www.marketinsightsreports.com/report/purchase/04301206616?mode=su?source=openpr&Mode=07

We Offer Customization on Report Based on Specific Client Requirement:
- Free country Level analysis for any 5 countries of your choice.
- Free Competitive analysis of any 5 key market players.
- Free 40 analyst hours to cover any other data point.

Note: All the reports that we list have been tracking the impact of COVID-19 the market. Both upstream and downstream of the entire supplychain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.

Contact Us:
Irfan Tamboli (Head of Sales) - Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

About Us:
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.